Daiken Medical Co., Ltd. (TYO:7775)
Japan
· Delayed Price · Currency is JPY 470.00
+4.00 (0.86%)
Mar 10, 2026, 10:47 AM JST
Daiken Medical Revenue
Daiken Medical had revenue of 2.82B JPY in the quarter ending December 31, 2025, with 2.62% growth. This brings the company's revenue in the last twelve months to 10.17B, up 1.57% year-over-year. In the fiscal year ending March 31, 2025, Daiken Medical had annual revenue of 9.95B with 2.06% growth.
Revenue (ttm)
10.17B
Revenue Growth
+1.57%
P/S Ratio
1.32
Revenue / Employee
56.48M
Employees
180
Market Cap
13.39B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 9.95B | 201.00M | 2.06% |
| Mar 31, 2024 | 9.75B | 613.00M | 6.71% |
| Mar 31, 2023 | 9.14B | 597.00M | 6.99% |
| Mar 31, 2022 | 8.54B | 679.00M | 8.64% |
| Mar 31, 2021 | 7.86B | -662.00M | -7.77% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| JTEC Corporation | 2.01B |
| SEED Co.,Ltd. | 33.57B |
| JMS Co.,Ltd. | 66.09B |
| Medius Holdings | 295.20B |
| KAINOS Laboratories | 4.44B |
| Shigematsu Works | 14.87B |
| ASO International | 3.95B |
| Medikit | 23.68B |
Daiken Medical News
- 5 weeks ago - Elastomeric Infusion Pumps Market worth $1.49 billion by 2030 at 5.3%, says MarketsandMarkets™ - Benzinga
- 3 months ago - Elastomeric Infusion Pumps Market worth $1.49 billion by 2030, at a CAGR of 5.3%, says MarketsandMarkets™ - Benzinga